CompaniesNeuroVive Pharmaceutical

NeuroVive Pharmaceutical

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

2

As Collaborator

1

Total Enrollment

236

By Phase

PHASE2: 2PHASE1: 1

By Status

COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
Today
NCT01825044
Hover over trial bars to see details

Recent Trials

NCT02397213Collaborator
Ciclosporin to Protect Renal Function In Cardiac Surgery
PHASE2Completed
155 participants
Started: Apr 30, 2015 · Completed: Sep 30, 2016
NCT01825044Lead Sponsor
Copenhagen Head Injury Ciclosporin (CHIC) Study
PHASE2Completed
16 participants
Started: Apr 30, 2013 · Completed: Sep 21, 2017
NCT01692834Lead Sponsor
A Study to Compare the Bioavailability and Pharmacokinetics of Cyclosporine After Intravenous Administration of NEUROSTAT®, a CREMOPHOR® EL-free Lipid Emulsion, and SANDIMMUNE® Injection (a Suspension of Cyclosporine in CREMOPHOR® EL) in Healthy Volunteers
PHASE1Completed
65 participants
Started: Jun 30, 2009 · Completed: Jan 31, 2010
Funding History (1)
D
May 27, 2015
Filing
NeuroVive Pharmaceutical | Biotech Hunter | Biotech Hunter